Archana Ganapathy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Archana Ganapathy has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Asif Khapedi
Basildon University Hospital, Basildon, United Kingdom
1 shared publication- Avinash Kumar
Department of Community Medicine, Kasturba Medical College, Mangalore, India
1 shared publication - Bhaskaran Unnikrishnan
Department of Community Medicine, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, India
1 shared publication - Darshan Bhagawan
Department of Community Medicine, Kasturba Medical College, Mangalore, India
1 shared publication Dawar Ujaas
Basildon University Hospital, Basildon, United Kingdom
1 shared publicationJohnson Samuel
Basildon University Hospital, Basildon, United Kingdom
1 shared publication
Latest Publications
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1617
Assessing the prevalence of pressurized Metered-dose Inhalers among COPD patients & their eligibility to switch to Dry Powdered Inhalers.
Introduction The impact of greenhouse gases on respiratory health is widely acknowledged, however, it is less well known that respiratory devices such as pressurized Metered Dose Inhalers (pMDI) contribute significantly to global warming due to propellant gases used in them. Aims and Objectives: 1. To assess the existing prevalence of pMDIs, and eligibility to switch to environmentally friendly Dry Powdered Inhalers (DPIs), among COPD patients in the Respiratory wards at a District General hospital in England, United Kingdom. 2. To assess the level of awareness among medical professionals regarding the environmental impact of pMDIs. Methodology: Over 2 weeks, 50 COPD patients were audited to assess the inhalers they use, their eligibility to switch to DPIs using Ellipta whistles and if the environmental sustainability of their inhalers held relevance to them. Simultaneously, a questionnaire was used to assess knowledge about the environmental impact of pMDIs among 16 medical professionals. Results: Out of 88 inhalers prescribed, 86.4% of them were pMDIs. 84.6% of patients expressed a desire to change to environmentally friendly inhalers and 74.0% of them were successfully able to use the Ellipta whistles. In the questionnaire, medical professionals scored a range of 4-7 points with an average score of 5.25 out of a total of 9 points. Conclusion: Given the willingness and suitability of COPD patients to be switched to DPIs, there is a significant potential to reduce carbon emissions by educating patients and medical professionals about the use/ prescription of environmentally friendly dry powdered inhalers.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA1617
Assessing the prevalence of pressurized Metered-dose Inhalers among COPD patients & their eligibility to switch to Dry Powdered Inhalers.
Introduction The impact of greenhouse gases on respiratory health is widely acknowledged, however, it is less well known that respiratory devices such as pressurized Metered Dose Inhalers (pMDI) contribute significantly to global warming due to propellant gases used in them. Aims and Objectives: 1. To assess the existing prevalence of pMDIs, and eligibility to switch to environmentally friendly Dry Powdered Inhalers (DPIs), among COPD patients in the Respiratory wards at a District General hospital in England, United Kingdom. 2. To assess the level of awareness among medical professionals regarding the environmental impact of pMDIs. Methodology: Over 2 weeks, 50 COPD patients were audited to assess the inhalers they use, their eligibility to switch to DPIs using Ellipta whistles and if the environmental sustainability of their inhalers held relevance to them. Simultaneously, a questionnaire was used to assess knowledge about the environmental impact of pMDIs among 16 medical professionals. Results: Out of 88 inhalers prescribed, 86.4% of them were pMDIs. 84.6% of patients expressed a desire to change to environmentally friendly inhalers and 74.0% of them were successfully able to use the Ellipta whistles. In the questionnaire, medical professionals scored a range of 4-7 points with an average score of 5.25 out of a total of 9 points. Conclusion: Given the willingness and suitability of COPD patients to be switched to DPIs, there is a significant potential to reduce carbon emissions by educating patients and medical professionals about the use/ prescription of environmentally friendly dry powdered inhalers.
- 23 July 2020
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 41 (1) , 108-113
Determinants of gestational diabetes mellitus: a hospital-based case–control study in coastal South India
- 23 July 2020
- Published by Springer Nature in International Journal of Diabetes in Developing Countries
- Vol. 41 (1) , 108-113
Determinants of gestational diabetes mellitus: a hospital-based case–control study in coastal South India